Title:
PEPTIDE COMPOUNDS AND PEPTIDE CONJUGATES FOR TREATMENT OF CANCER THROUGH RECEPTOR-MEDIATED CHEMOTHERAPY
Document Type and Number:
Japanese Patent JP2020189867
Kind Code:
A
Abstract:
To provide peptide compounds and conjugate compounds for treating cancer and uses thereof for medicinal applications.SOLUTION: A peptide compound having a specific amino acid sequence, where at least one protecting group and/or at least one labelling agent may be connected at N terminal and/or C terminal.SELECTED DRAWING: None
Inventors:
RICHARD BELIVEAU
BORHANE ANNABI
MICHEL DEMEULE
ALAIN LAROCQUE
JEAN-CHRISTOPHE CURRIE
CYNDIA CHARFI
BORHANE ANNABI
MICHEL DEMEULE
ALAIN LAROCQUE
JEAN-CHRISTOPHE CURRIE
CYNDIA CHARFI
Application Number:
JP2020135993A
Publication Date:
November 26, 2020
Filing Date:
August 11, 2020
Export Citation:
Assignee:
TRANSFERT PLUS SEC
International Classes:
C07K14/195; A61K31/12; A61K31/337; A61K31/704; A61K38/16; A61K47/64; A61P35/00; A61P35/02; A61P43/00; C07K14/47
Other References:
ONCOTARGET, vol. 6, JPN6019048351, March 2015 (2015-03-01), pages 10473 - 10486, ISSN: 0004619701
JOURNAL OF BIOLOGICAL CHEMISITRY, vol. 285, JPN6019048352, 2010, pages 12210 - 12222, ISSN: 0004619702
AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY, vol. 6, JPN6019048353, 2014, pages 169 - 177, ISSN: 0004619703
JOURNAL OF BIOLOGICAL CHEMISITRY, vol. 285, JPN6019048352, 2010, pages 12210 - 12222, ISSN: 0004619702
AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY, vol. 6, JPN6019048353, 2014, pages 169 - 177, ISSN: 0004619703
Attorney, Agent or Firm:
Asamura patent office